A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405
- Citation:
- J Clin Oncol vol 33 (suppl) abstr 3599
- Meeting Instance:
- ASCO 2015
- Year:
- 2015
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- This study also received support from Bristol-Myers Squibb, Genentech, and Pfizer
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 3326
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, CA31946
- Corr. Author:
- Authors:
- Federico Innocenti Kouros Owzar Chen Jiang Alexander B. Sibley Donna Niedzwiecki Heinz-Josef Lenz Monica M. Bertagnolli Paula N. Friedman Yoichi Furukawa Michiaki Kubo Mark J. Ratain Charles David Blanke Alan P. Venook Howard McLeod
- Networks:
- CA011, CA136, LAPS-IL036, LAPS-IL057, LAPS-MA036, LAPS-NC007, OR013
- Study
- CALGB-80405
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: